Clinical Expertise
- Amyloidosis
- Bone Marrow Disorders
- Cancer Of The Blood And Blood Cells
- Clotting Disorders
- Diagnosis Of Bleeding Or Clotting Disorders
- Hodgkin's Lymphoma
- Leukemia
- Lymphoma
- Multiple Myeloma
- Non-Hodgkin's Lymphoma
About Dr. Nand
Interests
Reading, Running, ChessMedical Education
Medical School
Amritsar Medical College/Punjab University, IndiaResidency
Amritsar Medical College HospitalIndia - Internal Medicine: General
Sir HN Hospital
India - Internal Medicine: General
VA Medical Center
North Chicago/Chicago Medical School - Internal Medicine: General
Fellowship
- Northwestern University McGaw Medical Center - Internal Medicine: Hematology & Medical Oncology
Board Certification
American Board of Internal Medicine Subspecialty Hematology
American Board of Internal Medicine Subspecialty Medical Oncology
American Board of Internal Medicine, Medical Oncology
American Board of Internal Medicine Subspecialty Medical Oncology
American Board of Internal Medicine, Medical Oncology
Research
- Myeloproliferative Neoplasms Nand, S., The New England journal of medicine
- Neurological Complications of the Leukemias Across the Ages Berg, S.; Nand, S., Current neurology and neuroscience reports
- Sensitizing leukemia stem cells to NF-kappaB inhibitor treatment in vivo by inactivation of both TNF and IL-1 signaling Li, J.; Volk, A.; Zhang, J.; Cannova, J.; Dai, S.; Hao, C.; Hu, C.; Sun, J.; Xu, Y.; Wei, W.; Breslin, P.; Nand, S.; Chen, J.; Kini, A.; Zhu, J.; Zhang, J., Oncotarget
- Association between early promoter-specific DNA methylation changes and outcome in older acute myeloid leukemia patients Achille, N. J.; Othus, M.; Phelan, K.; Zhang, S.; Cooper, K.; Godwin, J. E.; Appelbaum, F. R.; Radich, J. P.; Erba, H. P.; Nand, S.; Zeleznik-Le, N. J., Leukemia research
- Relationhip between event-free survival and overall survival in acute myeloid leukemia: A report from SWOG HOVN/SAKK, and MRC/NCRI, Othus, M.; van Putten, W.; Lowenberg, B.; Petersdorf, S. H.; Nand, S.; Erba, H.; Appelbaum, F.; Hills, R.; Russell, N.; Burnett, A.; Estey, E., Haematologica
- Sensitizing acute myeloid leukemia cells to induced differentiation by inhibiting the RIP1/RIP3 pathway Xin, J.; You, D.; Breslin, P.; Li, J.; Zhang, J.; Wei, W.; Cannova, J.; Volk, A.; Gutierrez, R.; Xiao, Y.; Ni, A.; Ng, G.; Schmidt, R.; Xia, Z.; Pan, J.; Chen, H.; Patel, M. M.; Kuo, P. C.; Nand, S.; Kini, A. R.; Zhang, J.; Chen, J.; Zhu, J.; Zhang, J., Leukemia
- Anaplastic large cell lymphoma involving the urinary bladder: a case report and review of the literature Chen, H.; Li, Y.; Nand, S.; Quek, M. L.; Kini, A. R.; Barkan, G. A., Diagnostic cytopathology
- FAK Mediates a Compensatory Survival Signal Parallel to PI3K-AKT in PTEN-Null T-ALL Cells You, D.; Xin, J.; Volk, A.; Wei, W.; Schmidt, R.; Scurti, G.; Nand, S.; Breuer, E. K.; Kuo, P. C.; Breslin, P.; Kini, A. R.; Nishimura, M. I.; Zeleznik-Le, N. J.; Zhang, J., Cell reports
- Anemias excluding cobalamin and folate deficiencies Dublis, S.; Shah, S.; Nand, S.; Anderes, E., Handbook of clinical neurology
- Co-inhibition of NF-kappaB and JNK is synergistic in TNF-expressing human AML Volk, A.; Li, J.; Xin, J.; You, D.; Zhang, J.; Liu, X.; Xiao, Y.; Breslin, P.; Li, Z.; Wei, W.; Schmidt, R.; Li, X.; Zhang, Z.; Kuo, P. C.; Nand, S.; Zhang, J.; Chen, J.; Zhang, J., The Journal of experimental medicine
- Commonly used drugs in hematologic disorders Anderes, E.; Nand, S., Handbook of clinical neurology
- Heckathorn disease revisited Nand, S.; Barton, K.; Schultz, R.; Klein, M.; Kini, A., Blood
- A phase 2 trial of azacitidine and gemtuzumab ozogamicin therapy in older patients with acute myeloid leukemia Nand, S.; Othus, M.; Godwin, J. E.; Willman, C. L.; Norwood, T. H.; Howard, D. S.; Coutre, S. E.; Erba, H. P.; Appelbaum, F. R., Blood
- Cerebral Vein and Dural Venous Sinus Thrombosis: Risk Factors Prognosis and Treatment—a Modern Approach, Paner, A.; Jay, W. M.; Nand, S.; Michaelis, L. C., Neuro-Ophthalmology
- Hydroxyurea azacitidine and gemtuzumab ozogamicin therapy in patients with previously untreated non-M3 acute myeloid leukemia and high-risk myelodysplastic syndromes in the elderly: results from a pilot trial, Nand, S.; Godwin, J.; Smith, S.; Barton, K.; Michaelis, L.; Alkan, S.; Veerappan, R.; Rychlik, K.; Germano, E.; Stiff, P., Leukemia & lymphoma
- Inherited thrombophilia and the eye Czerlanis, C.; Jay, W. M.; Nand, S., Seminars in ophthalmology
- Single agent lenalidomide induces a response in refractory T-cell posttransplantation lymphoproliferative disorder Portell, C.; Nand, S., Blood
- Blast crisis in chronic myelogenous leukemia remains a difficult therapeutic challenge Nand, S.; Barton, K., Leukemia & lymphoma
- A unique case of acute promyelocytic leukemia showing monocytic differentiation after ATRA (all-trans retinoic acid) therapy. Naeem, M.; Harrison, K.; Barton, K.; Nand, S.; Alkan, S., European journal of haematology
- Thromboembolism in cancer patients: pathogenesis and treatment Adess, M.; Eisner, R.; Nand, S.; Godwin, J.; Messmore, H. L., Jr; Wehrmacher, W. H., Clinical & Applied Thrombosis/Hemostasis
- Survival role of protein kinase C (PKC) in chronic lymphocytic leukemia and determination of isoform expression pattern and genes altered by PKC inhibition. Alkan, S.; Huang, Q.; Ergin, M.; Denning, M. F.; Nand, S.; Maududi, T.; Paner, G. P.; Ozpuyan, F.; Izban, K. F., American Journal of Hematology
- A randomized controlled trial of darbepoetin alfa administered as a fixed or weight-based dose using a front-loading schedule in patients with anemia who have nonmyeloid malignancies Hesketh, P. J.; Arena, F.; Patel, D.; Austin, M.; D'Avirro, P.; Rossi, G.; Colowick, A.; Schwartzberg, L.; Bertoli, L. F.; Cole, J. T.; Demetri, G.; Dessypris, E.; Dobbs, T.; Eisenberg, P.; Fleischman, R.; Hall, J.; Hoffman, P. C.; Laber, D. A.; Leonard, J.; Lester, E. P.; McCachren, S.; McMeekin, S.; Meza, L.; Miller, D. S.; Nand, S.; Oliff, I.; Paroly, W.; Pawl, L.; Perez, A.; Raftopoulos, H.; Rigas, J.; Rowland, K.; Scullin, D. C., Jr; Tezcan, H.; Waples, J.; Ward, J.; Yee, L. K., Cancer
- Herpes zoster during treatment with arsenic trioxide Tanvetyanon, T.; Nand, S., Annals of Hematology
- Lymphoproliferative disorders in chronic hepatitis C. Idilman, R.; Colantoni, A.; De Maria, N.; Alkan, S.; Nand, S.; Van Thiel, D. H., Journal of viral hepatitis
- Overexpression of the NOTCH ligand JAG2 in malignant plasma cells from multiple myeloma patients and cell lines. Houde, C.; Li, Y.; Song, L.; Barton, K.; Zhang, Q.; Godwin, J.; Nand, S.; Toor, A.; Alkan, S.; Smadja, N. V.; Avet-Loiseau, H.; Lima, C. S.; Miele, L.; Coignet, L. J., Blood
- Pancytopenia in hereditary haemorrhagic telangiectasia. Tanvetyanon, T.; Nand, S., British journal of haematology
- Hairy cell leukemia variant developing in a background of polycythemia vera Kelly, N. P.; Alkan, S.; Nand, S., Archives of Pathology & Laboratory Medicine
- Overcoming recurrent cutaneous reactions from imatinib using once-weekly dosing. Tanvetyanon, T.; Nand, S., Annals of Pharmacotherapy
- Hepatitis C virus infection and lymphoproliferative disorders Pena, L. R.; Nand, S.; De Maria, N.; Van Thiel, D. H., Digestive diseases and sciences
